The Cigna Group (CI)
The Cigna Group is a massive American health services company that provides insurance plans and manages pharmacy benefits for millions of people.
Is The Cigna Group a good stock for a UK beginner?
The honest version: The Cigna Group is a massive American health services company that provides insurance plans and manages pharmacy benefits for millions of people.
Over about 2 years to 2026-07-31. This is the share price only - reinvesting the dividends would add to it. And it's the USD return - as a UK investor your actual £ return also moves with the exchange rate. Past performance is not a guide to the future, and it could just as easily have fallen.
Prices move on results, news and the mood of the whole market - no single headline explains a day, and a quiet week is usually just noise, not a signal.
Long-term success in integrating health services and technology.
Major structural changes to the US private insurance model.
What does The Cigna Group do?
Cigna operates as a giant middleman in the US healthcare system, helping people pay for medical care and managing the complex world of prescription drugs. Insurance premiums and fees for their pharmacy services are what fill the coffers. How it navigates the constant changes in US government healthcare policy and the rising costs of medical treatments is the thing to follow.
On our factor screen it looks strongest on value and income, and weakest on quality.
- ✓Pays a dividend - about 2.2% a year
- ✓Growing - revenue up about 7% over the year
- !Thin profits - turns only about 2% of sales into profit
- ·Low P/E of 12 vs last year's earnings
- ✓Strong return on shareholder money (ROE 17%)
- Value screens high (87/100)
- Income screens high (71/100)
- Strong earnings growth compared to the previous year
- Low share price volatility compared to the broader market
- Provides a consistent dividend income for shareholders
- Potential for significant changes to US government healthcare policy
- Intense competition from other large health insurers
- Rising medical costs that could squeeze profit margins
What do The Cigna Group's numbers mean?
How much money does The Cigna Group make?
Revenue and profit by quarter, and how much of each sale turns into profit.
Does The Cigna Group pay a dividend?
Yes - The Cigna Group currently pays a dividend of about 2.2% a year (the yearly payout as a share of the price). A dividend is a slice of profit handed to shareholders; the yield moves as the price moves, and a company can cut or stop it.
When does The Cigna Group report earnings, and how did recent quarters go?
The Cigna Group is next scheduled to report on about 2026-11-05 - dates can move, and we don't predict results; this just tells you when to look.
Each quarter a company reports its results against what analysts expected. ‘Beating’ or ‘missing’ is about that expectation, not whether the business is doing well in absolute terms.
| Reported | Expected EPS: The earnings per share analysts expected for the quarter - the average of their forecasts. 'Beating' or 'missing' is measured against this number. | Actual EPS | vs expected |
|---|---|---|---|
| 2026-07-30 | $7.60 | $7.78 | Beat +2% |
| 2026-04-30 | $7.61 | $7.79 | Beat +2% |
| 2026-02-05 | $7.88 | $8.08 | Beat +2% |
| 2025-10-30 | $7.64 | $7.83 | Beat +2% |
| 2025-07-31 | $7.15 | $7.20 | In line |
| 2025-05-02 | $6.35 | $6.74 | Beat +6% |
Across the last 6 quarters here, The Cigna Group came in ahead of what analysts expected 5 times. One quarter is noise, not a trend.
See who else reports over the next two weeks →
Reported vs expected earnings per share (EPS) from published results; the expectation is the analyst consensus, not our view. Report dates are estimates that can move.
More in Healthcare
Eli Lilly
West Pharmaceutical Services, Inc.
Incyte Corporation
Zimmer Biomet Holdings, Inc.
Moderna, Inc.
Gilead Sciences, Inc.
Regeneron Pharmaceuticals, Inc.
Agilent Technologies, Inc.What are the scenarios for The Cigna Group?
An illustrative range for the year ahead, with the assumption behind each case — not a prediction or a price target.
What are the pros and cons of The Cigna Group?
How many points the write-up makes each way — a balance check, not a score or verdict.
- Strong earnings growth compared to the previous year
- Low share price volatility compared to the broader market
- Provides a consistent dividend income for shareholders
- Solid return on equity showing efficient use of capital
- Very thin profit margins leave little room for error
- Operates in a highly complex and heavily regulated industry
- Revenue growth is relatively modest
- Potential for significant changes to US government healthcare policy
- Intense competition from other large health insurers
- Rising medical costs that could squeeze profit margins
The write-up's own warning lights — if these start happening, the case above changes.
- A major overhaul of the US healthcare system that removes private insurers
- A sustained, significant drop in the number of people using private health insurance
Built from public filings & market prices, checked for an education-only tone, and never a price target. How we make these →
This plain-English summary was auto-generated on 2026-08-01 from public data and checked for an education-only, no-advice tone (the figures above carry their own, usually fresher, 'as of' date). It's information, never a recommendation.